Stediril

OBJECTIVE This study aimed to compare the effects on hemostasis variables of a contraceptive vaginal ring with those of an oral… Expand

OBJECTIVE To investigate the effect of two oral contraceptives containing 0.02 mg ethinylestradiol and 0.1 mg levonorgestrel… Expand

In the present study the effect on the urinary excretion of vasoactive markers of two oral contraceptives (OCs), i.e., Leios… Expand

A case of upper extremity venous thrombosis due to Stediril, a hormonal contraceptive is reported in a 44-year old woman… Expand

33 women, aged 20-41 years, used the contraceptive preparation Stediril, produced by the firm Wyeth, over the course of 6… Expand

94 women whose nonpregnancy was verified were examined. 57 were examined before the administration of the oral contraceptive… Expand

40 women used Stediril as a contraceptive for an average of 9.1 months. The preparation was observed to be 100% effective when… Expand

The authors prescribed Stediril (.5 (sic) mg ethinyl estradiol and .5 mg norgestrel combined) for 328 women totaling 185 cycles… Expand

Stediril (.5 mg norgestrel and .05 mg ethinyl estradiol combined) was taken by 130 French women aged 19-52 for 3-18 cycles for a… Expand

Preliminary results of a prospective study of 2026 women who took Stediril (an effective dose of .25 mg d-norgestrel plus .05 mg… Expand